Genome Editing Technology & IP Landscape Dashboard

Genome Editing Technology & IP Landscape Dashboard

299.00 every month 499.00 every month

UPDATED MONTHLY

Genome Editing landscape overview

Genome editing (also called genome engineering) is a group of technologies that allow specific changes to the DNA of a cell or organism. Genetic materials such as DNA are inserted, deleted, altered or replaced at site specific locations in the genome.

Recent advances in genome editing technologies such as Zinc Finger Nucleases (ZFNs), Transcription activator-like effector nucleases (TALEN), Antisense RNA, and Adenine Base Editor (ADE) have substantially improved our ability to make precise alteration in the genomes to correct or introduce genetic modification for treating diseases that are refractory to traditional therapies. In particular, the CRISPR/Cas system shows a significant advantage over ZFN and TALEN in targeting numerous genome sites.

Major players covered in this landscape

Addgene, Agilent Technologies, Cellectis group, Crispr therapeutics, Genscript, Innovative Genomics Initiative, Integrated DNA technologies, Lonza, Merck, Sangamo therapeutics, Thermo fisher scientific, Transomic Technologies, Transposagen Biopharmaceuticals and University of California.

sale
Subscribe

Gain and share insights visually and intuitively with the Intellar® landscape experience

INT_Intellar_v5_competitive-intelligence-dashboard-screenshots-1500.gif
 

Other available Life Science landscapes

 

The growing Intellar Library